TNFα production by CD4 + T cells predicts long-term increase in lesion load on MRI in MS
- 25 September 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (6) , 1129-1131
- https://doi.org/10.1212/wnl.57.6.1129
Abstract
Reliable laboratory prognostic factors for MS are still lacking. The predictive value of markers of T-cell activation for long-term disease progression was investigated. Flow cytometry measurements were correlated to changes in Expanded Disability Status Scale and MR T2 lesion load over 36 months in 14 patients with secondary progressive MS. A correlation was found between the percentage of tumor necrosis factor-α-producing CD4+ T cells at baseline and the change in T2 lesion load during 3-year follow-up (r = 0.79, adjusted r2 = 0.59, p = 0.001).Keywords
This publication has 10 references indexed in Scilit:
- Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosisAnnals of Neurology, 2000
- Changes in Activated T Cells in the Blood Correlate With Disease Activity in Multiple SclerosisArchives of Neurology, 2000
- CCR5+and CXCR3+T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesionsProceedings of the National Academy of Sciences, 1999
- Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsJournal of Clinical Investigation, 1999
- Increased Production of Tumor Necrosis Factor α, and Not of Interferon γ, Preceding Disease Activity in Patients With Multiple SclerosisArchives of Neurology, 1998
- Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosisAnnals of Neurology, 1998
- Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.Journal of Clinical Investigation, 1997
- Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activityAnnals of Neurology, 1995
- Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple SclerosisNew England Journal of Medicine, 1991
- Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosisPublished by Elsevier